Anabolik-Androjenik Steroidlerin Erektil Fonksiyon ve Fertiliteye Etkileri

Borell M. Organotherapy and the emergence of reproductive endocrinology. J Hist Biol. 1985;18:1-30.

Brown-Séquard CE. Note on the effects produced on man by subcutaneous injections of a liquid obtained from the testicles of animals. Lancet. 1889;134(3438):105-107.

Brown-Séquard CE. On a new therapeutic method consisting in the use of organic liquids extracted from glands and other organs. BMJ. 1893;1:1145-1147.

David K, Dingemanse E, Freud J, Laqueur E. Über krystallinisches männliches Hormon aus Hoden (Testosteron), wirksamer als aus Harn oder aus Cholesterin bereitetes Androsteron. Hoppe Seylers Z Physiol Chem. 1935;233:281-283.

Butenandt A, Hanisch G. Über die Umwandlung des Dehydro-androsterons in Δ4-Androsten-ol-(17)-on-(3) (Testosteron); ein Weg zur Darstellung des Testosterons aus Cholesterin. Ber Dtsch Chem Ges. 1935;68:1859-1862.

Nobel Prize Outreach. The Nobel Prize in Chemistry 1939: Adolf Friedrich Johann Butenandt and Leopold Ruzicka. NobelPrize.org. 1939.

Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502-521. doi:10.1038/bjp.2008.165.

Handelsman DJ. Commentary: androgens and “anabolic steroids”: the one-headed janus. Endocrinology. 2011;152(5):1752-1754. doi:10.1210/en.2010-1501.

Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24(5):383-398. doi:10.1016/j.annepidem.2014.01.009.

Mulawkar PM, Maheshwari PN, Gauhar V, Agrawal SG, Mohammed TO, Singh AG, et al. Use of anabolic-androgenic steroids and male fertility: a systematic review and meta-analysis. J Hum Reprod Sci. 2023;16(4):268-285. doi:10.4103/jhrs.jhrs_90_23.

Azevedo RA, Gualano B, Teixeira TA, Nascimento BCG, Hallak J. Abusive use of anabolic androgenic steroids, male sexual dysfunction and infertility: an updated review. Front Toxicol. 2024;6:1379272. doi:10.3389/ftox.2024.1379272.

Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil Steril. 2014;101(5):1271-1279. doi:10.1016/j.fertnstert.2014.02.002.

Coward RM, Rajanahally S, Kovac JR, Smith RP, Pastuszak AW, Lipshultz LI. Anabolic steroid induced hypogonadism in young men. J Urol. 2013;190(6):2200-2205. doi:10.1016/j.juro.2013.06.010.

Corona G, Rastrelli G, Marchiani S, Filippi S, Morelli A, Sarchielli E, et al. Consequences of anabolic-androgenic steroid abuse in males; sexual and reproductive perspective. World J Mens Health. 2022;40(2):165-178. doi:10.5534/wjmh.210021.

de Souza GL, Hallak J. Anabolic steroids and male infertility: a comprehensive review. BJU Int. 2011;108(11):1860-1865. doi:10.1111/j.1464-410X.2011.10131.x.

Nieschlag E, Vorona E. Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol. 2015;173(2):R47-R58. doi:10.1530/EJE-15-0080.

Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25(6):947-970. doi:10.1210/er.2003-0030.

Rajmil O, Moreno-Sepulveda J. Recovery of spermatogenesis after androgenic anabolic steroids abuse in men: a systematic review of the literature. Actas Urol Esp (Engl Ed). 2024;48(2):116-124. doi:10.1016/j.acuroe.2023.07.007.

Esposito M, Salerno M, Calvano G, Agliozzo R, Ficarra V, Sessa F, et al. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review. Panminerva Med. 2023;65(1):43-50. doi:10.23736/S0031-0808.22.04677-8.

Huijben M, Lock MTW, de Kemp VF, de Kort LMO, van Breda HMK. Clomiphene citrate for men with hypogonadism: a systematic review and meta-analysis. Andrology. 2022;10(3):451-469. doi:10.1111/andr.13146.

Hohl A, Chavez MP, Pasqualotto E, Ferreira ROM, van de Sande-Lee S, Ronsoni MF. Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Arch Endocrinol Metab. 2025;69(5):e250093. doi:10.20945/2359-4292-2025-0093.

McBride JA, Coward RM. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl. 2016;18(3):373-380. doi:10.4103/1008-682X.173938.

Gazvani MR, Buckett W, Luckas MJ, Aird IA, Hipkin LJ, Lewis-Jones DI. Conservative management of azoospermia following steroid abuse. Hum Reprod. 1997;12(8):1706-1708. doi:10.1093/humrep/12.8.1706.

Turek PJ, Williams RH, Gilbaugh JH 3rd, Lipshultz LI. The reversibility of anabolic steroid-induced azoospermia. J Urol. 1995;153(5):1628-1630.

Menon DK. Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin. Fertil Steril. 2003;79(Suppl 3):1659-1661. doi:10.1016/S0015-0282(03)00365-0.

Al Hashimi M, Pinggera GM, Shah R, Agarwal A. Clinician's guide to the management of azoospermia induced by exogenous testosterone or anabolic-androgenic steroids. Asian J Androl. 2025;27(3):330-341. doi:10.4103/aja2024104.

Karila D, Kerlan V, Christin-Maitre S. Androgenic steroid excess in women. Ann Endocrinol (Paris). 2024;85(2):142-149. doi:10.1016/j.ando.2023.11.001.

Santos BM, de Souza JPA, Goulart LRP, Petrine JCP, Alves FHF, Del Bianco-Borges B. Impacts of anabolic-androgenic steroid supplementation on female health and offspring: mechanisms, side effects, and medical perspectives. Saudi Pharm J. 2024;32(12):102205. doi:10.1016/j.jsps.2024.102205.